Entering text into the input field will update the search result below

Xenon Pharma GAAP EPS of -$1.77 misses by $1.41, revenue of $18.43M beats by $12.13M

Mar. 01, 2022 4:06 PM ETXenon Pharmaceuticals Inc. (XENE)By: Urvi Shah, SA News Editor
  • Xenon Pharma press release (NASDAQ:XENE): Q4 GAAP EPS of -$1.77 misses by $1.41.
  • Revenue of $18.43M (-42.7% Y/Y) beats by $12.13M.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About XENE

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Xenon Pharmaceuticals Inc.
Zai Lab Limited
Biohaven Ltd.
Intellia Therapeutics, Inc.
MoonLake Immunotherapeutics
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.